Marco Ferrara

R & d Team Leader @Flamma

Milan, IT
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2018 — Present

R & d Team Leader @Flamma

View department →

Milan, IT

EDUCATION

1991 — 1998

Università degli Studi di Firenze

Laurea, Chemistry

2009 — 2010

Sapienza Università di Roma

Master, Industrial pharmaceutical methodologies

1999 — 2002

University of Bristol

PhD, Chemistry

SKILLS

Organic ChemistryRegulatory AffairsDrug MetabolismDmpkDrug DesignPharmaceutical IndustryChemistryProcess ChemistryIn VivoChromatographyScienceCgmpOrganic SynthesisDrug DiscoveryR&DPurificationLead OptimizationPharmaceuticalsLifesciencesMedicinal ChemistryLife SciencesNmrPharmaceutical ResearchSynthetic ChemistryResearch and Development (R&D)

ABOUT MARCO FERRARA

Management of resources and of activities- supervision of technicians with periodic performance evaluation and development planning - planning of chemistry lab activities involving synthesis of APIs and their intermediates • Project leadership: start, progression and final delivery of candidate drugs into the various phases of development • Team leadership or membership in international and multidisciplinary settings including collaborations. Key contributor in development projects. Active role in cross-functional teams, global networks and department management teams • Technical expertise- synthesis of high quality APIs including development of synthetic pathways and manufacturing processes towards new pharmaceutical intermediates and bulk drugs; plant support work and bench to plant process technology transfer. Process performance improvement including sustainability and reduction of environmental footprint - experienced in several TAs and in all stages of DD - IP protection: patent drafting, definition of patent strategy, analysis of prior art and FtO, patent busting, inventorship determination - Inventor/author of several patents, publications and oral presentations • Identification of several preclinical candidates, including the currently marketed drugs Raltegravir (Isentress®), a first-in-class drug for HIV therapy, and Grazoprevir (Zepatier®), an HCV protease inhibitor with high genetic barrier to resistance

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Marco Ferrara — R & d Team Leader at Flamma in Milan, IT | Unifers